Plants as bioreactors: Recent developments and emerging opportunities.

Area of Science:

• Biotechnology and Molecular Farming
• Plant Molecular Biology
• Recombinant Protein Production

Background:

• Plant bioreactors offer a low-cost, safe, and scalable method for producing recombinant proteins.
• Advances in genetic engineering have significantly improved the efficiency and yield of protein expression in plants.

Purpose of the Study:

• To review strategies for enhancing protein expression in transgenic plants.
• To highlight the diverse range of products being developed using plant-based systems.
• To assess the commercial viability and market progression of plant-derived recombinant proteins.

Main Methods:

• Review of various strategies to boost protein expression, including transcriptional augmentation, transcript stabilization, and targeted accumulation.
• Analysis of different product classes produced in plants, such as vaccine antigens, diagnostics, and biopolymers.
• Examination of the clinical trial and market entry status of plant-derived recombinant proteins.

Main Results:

• Multiple strategies effectively enhance protein yield and concentration in transgenic plants.
• Plant bioreactors are capable of producing a wide array of complex molecules, including pharmaceuticals and nutritional supplements.
• A significant number of plant-derived recombinant proteins have advanced to clinical trials, with some already commercialized.

Conclusions:

• Plant bioreactors represent a powerful and economically viable platform for the production of valuable biomolecules.
• Continued research into optimizing expression strategies will further expand the applications of plant-based manufacturing.
• The successful market introduction of several products validates the potential of plant molecular farming.